An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target

BackgroundEndometriosis is a chronic, heterogeneous disease with limited non-hormonal treatment options. Drug repurposing provides an accelerated route to identify safe, tolerable, and potentially effective therapies for endometriosis. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) was inves...

Cijeli opis

Bibliografski detalji

Glavni autori:	Kate Gunther, Dongli Liu, Gill Stannard, Melissa Holmes, Christine Loo, Belinda Guo, Nikola Bowden, Jason Abbott, Caroline E. Ford
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-12-01
Serija:	Frontiers in Pharmacology
Teme:	endometriosis drug repurposing Ror1 organoid reimegepant
Online pristup:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1716062/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!